Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for autologous hematopoietic stem cell transplant support
IRCT20100127003210N20Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in cancer comparing Melatonin + G-CSF with Placebo + G-CSF (2 arms). Primary endpoints: CD34 changes, Engraftment duration and 3 more. Started Nov 2019; status: completed.
02
Drugs
melatonin
03
Conditions
cancer
Beyond the preview
Go deeper on IRCT20100127003210N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N20.